Netherlands Artificial Organs & Bionic Implants Market

Netherlands Artificial Organs & Bionic Implants Market by Products (Artificial Organs [Artificial Heart, Artificial Kidney] and Bionics [Vision Bionics, Orthopedic Bionic, Cardiac Bionics, Others]) and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2039
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 215
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Netherlands artificial organs & bionic implants market size is anticipated to expand at a substantial CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increasing prevalence of disabilities and organ failures and rising healthcare expenditure.

Netherlands Artificial Organs & Bionic Implants Market

Artificial organs comprise complex medical devices that have active mechanical or biochemical functions. Heart, lungs, kidneys, liver, pancreas, and neurosensory organs are available in form of artificial organ. These organs can be either surgically implanted or extracorporeal. The latter is a medical procedure where blood is temporarily processed outside the patient's body.

Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently abled person. The bionics industry has expanded across four major application areas that are vision, hearing, orthopedics and cardiac implants.

In the Netherlands, ischemic heart disease is found to be the leading cause of death. Based on data from the European Health Interview Survey (EHIS), one in six people in the Netherlands lives with hypertension, which is a major risk factor for cardiovascular disease. Cardiovascular diseases are found to have a major share in the deaths in the country. Increasing prevalence of cardiovascular disease patients and increasing demand for cardiac bionics are boosting the market growth.

Market Trends, Drivers, Restraints, and Opportunities:

  • Growing technological advancements and increasing awareness about bionics and artificial organs are driving the market growth.
  • Increasing number of accidents and injuries leading to amputations is anticipated to augment the Netherlands artificial organs & bionic implants market growth.
  • Limited surgical expertise and high cost for development of bionic implants and artificial organs can restrain the growth of the market.
  • High cost of devices that are used to make and implant these implants and artificial organs and uncertain reimbursement scenarios in the country can hinder the market growth.
  • Rising trend of improving income levels is expected to propel the market growth.
  • Increasing number of government initiatives to proliferate the development of the healthcare industry and rising investment of the government state bodies in the industry are expected to create lucrative opportunities during the forecast period.

Scope of the Report

The report on the Netherlands artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Netherlands Artificial Organs & Bionic Implants Market -  Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Artificial Organs [Artificial Heart, Artificial Kidney], Bionics [Vision Bionics, Orthopedic Bionic, Cardiac Bionics, Others])

Geographical Zone

Netherland

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Orthofix International N.V, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc , Reboocon Bionics B.V., and Ossur hf

Netherlands Artificial Organs & Bionic Implants Market Segment Insights:

Bionics segment to grow at a rapid pace

Based on products, the market is divided into artificial organs and bionics. The artificial organs segment is further divided into artificial heart, artificial kidney, and others. On the other hand, the bionics segment is segregated into vision bionics, orthopedic bionic, cardiac bionics, and others. The bionics segment is anticipated to account for a key share and is anticipated to grow at a steady rate due to the increasing number of knee replacement and hip replacement surgeries that are taking place in the country. Moreover, rising geriatric population is  expected to contribute to the segment growth due to increasing joint replacements requirements among elderly patients.

The artificial segment is anticipated to account for a healthy grow rate during the forecast period. Ongoing technological advancement to lower the cost of implantation of artificial organs is driving the segment growth. Moreover, the improvement in reimbursement scenario in the country is expected to foster the growth of the segment.

Netherlands Artificial Organs & Bionic Implants Market

Segments

Segments Covered in the Report

The Netherlands artificial organs & bionic implants market has been segmented on the basis of

Product

  • Artificial organs
    • Artificial Heart
    • Artificial Kidney
  • Bionics
    • Vision Bionics
    • Orthopedic Bionic
    • Cardiac Bionics
    • Others

Country

  • Netherland

Key Players

  • Orthofix International N.V
  • Boston Scientific Corporation
  • Otto Bock Holding GmbH & Co. KG
  • Medtronic plc  
  • Reboocon Bionics B.V.  
  • Ossur hf

Competitive Landscape

The major players of the market are Orthofix International N.V, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Reboocon Bionics B.V., and Ossur hf.

Companies are engaging in agreements, planning on collaborative models, focusing on innovation, working on strategies to increase the number of projects, and focusing on acquisitions and mergers in order to  increase their customer base.

Netherlands Artificial Organs & Bionic Implants Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Artificial Organs & Bionic Implants Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Artificial Organs & Bionic Implants Market - Supply Chain
  4.5. Global Artificial Organs & Bionic Implants Market Forecast
     4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
6. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
  11.2. Artificial Organs & Bionic Implants Distributors and Customers
  11.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Orthofix International N.V Boston Scientific Corporation Otto Bock Holding GmbH & Co. KG Medtronic plc   Reboocon Bionics B.V.   Ossur hf

Segments Covered in the Report

The Netherlands artificial organs & bionic implants market has been segmented on the basis of

Product

  • Artificial organs
    • Artificial Heart
    • Artificial Kidney
  • Bionics
    • Vision Bionics
    • Orthopedic Bionic
    • Cardiac Bionics
    • Others

Country

  • Netherland

Key Players

  • Orthofix International N.V
  • Boston Scientific Corporation
  • Otto Bock Holding GmbH & Co. KG
  • Medtronic plc  
  • Reboocon Bionics B.V.  
  • Ossur hf

The major players of the market are Orthofix International N.V, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Reboocon Bionics B.V., and Ossur hf.

Companies are engaging in agreements, planning on collaborative models, focusing on innovation, working on strategies to increase the number of projects, and focusing on acquisitions and mergers in order to  increase their customer base.

Netherlands Artificial Organs & Bionic Implants Market

Buy Report